Puishys Joseph F. 4
4 · APOGEE ENTERPRISES, INC. · Filed Nov 12, 2020
Insider Transaction Report
Form 4
Puishys Joseph F.
DirectorChief Executive Officer & Pres
Transactions
- Sale
Common Stock
2020-11-10$25.56/sh−58,883$1,504,949→ 155,460 total - Exercise/Conversion
Option (Right to Buy)
2020-11-09−41,458→ 58,883 totalExercise: $8.34Exp: 2021-08-22→ Common Stock (41,458 underlying) - Exercise/Conversion
Option (Right to Buy)
2020-11-10−58,883→ 0 totalExercise: $8.34Exp: 2021-08-22→ Common Stock (58,883 underlying) - Sale
Common Stock
2020-11-09$25.99/sh−41,458$1,077,676→ 155,460 total - Exercise/Conversion
Common Stock
2020-11-10$8.34/sh+58,883$491,084→ 214,343 total - Exercise/Conversion
Common Stock
2020-11-09$8.34/sh+41,458$345,760→ 196,918 total
Holdings
- 127,175(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Includes restricted stock awards under the 2009 Stock Incentive Plan and 2019 Stock Incentive Plan.
- [F2]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2020 which was reported on a Form 8-K filed September 25, 2020.
- [F3]The price reported is the weighted average sale price for the transactions reported. The prices received ranged from $25.21 to $26.90. The Reporting Person will provide to the issuer, a security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range.
- [F4]The price reported is the weighted average sale price for the transactions reported. The prices received ranged from $25.01 to $25.81. The Reporting Person will provide to the issuer, a security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range.
- [F5]Currently 100% exercisable.